Heart attack

April 17, 2018

Bonding your way to regenerate the lost cardiomyocytes in Myocardial patients: Oxytocin-based intranasal inhalation therapy for cardiac diseases: Oxytocin, a peptide hormone and neuropeptide known to play a role in empathy, generosity, child birth and so on,  increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down regulation of its target gene, 17/April/2018, 2.21 pm

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]
April 17, 2018

Bonding your way to say no to Cardiomyopathy: Oxytocin-based intranasal inhalation therapy for Cardiomyopathy: Oxytocin, a peptide hormone and neuropeptide known to play a role in empathy, generosity, child birth and so on , decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy, via up regulation of its target gene, 17/April/2018, 1.48 pm

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]
April 16, 2018

An oxytocin-way to say no to cardiac diseases: Oxytocin-based inhalation therapy for attenuating pathogenesis-associated with Myocardial infarction: Inhalation of oxytocin decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 16/April/2018, 8.05 am

Introduction: What they say: A recent study from Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA; and Cardiovascular Research Center, Massachusetts General Hospital and […]
April 13, 2018

An omega-3 way to say no to Cardiomyopathy: PUFA-based therapy for Cardiomyopathy: ω-PUFAs (Docosahexaenoic acid (DHA) + Eicosapentaenoic acid (EPA)) decrease the expression of Sox6, restore the balance between slow- and fast-twitch myofiber proteins and alleviate Cardiomyopathy via up regulation of its target gene, 13/April/2018, 10.05 pm

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]